Matti Kivikko
Matti Kivikko publishes mostly in Cardiology and Cardiovascular Medicine, Biomedical Engineering and Pulmonary and Respiratory Medicine, on topics such as Heart Failure Treatment and Management, Atrial Fibrillation Management and Outcomes and Cardiovascular Function and Risk Factors.
- World rank
- #255,712 of 7,710,434 ranked researchers
- Rank in Finland
- #1,434 of 37,370
- Works
- 62
- Citations
- 4.6k
- Citations per work
- 74.1
What does Matti Kivikko research?
Matti Kivikko's work is mostly in Medicine (81%), Engineering (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5081.2%
- Medicine5081.2%
- Everything else711.6%
- Physical Sciences47.2%
- Engineering47.2%
- 1Cardiology and Cardiovascular Medicine66% of their works
- 2Biomedical Engineering7% of their works
- 3Pulmonary and Respiratory Medicine6% of their works
- 4Endocrinology, Diabetes and Metabolism4% of their works
- 5Surgery4% of their works
- 6Epidemiology2% of their works
Research topics
- Heart Failure Treatment and Management
- Atrial Fibrillation Management and Outcomes
- Cardiovascular Function and Risk Factors
- Mechanical Circulatory Support Devices
- Cardiac pacing and defibrillation studies
- Cardiac, Anesthesia and Surgical Outcomes
- Potassium and Related Disorders
- Cardiac Structural Anomalies and Repair
Which keywords describe Matti Kivikko's research?
The keywords of their largest research topics: Heart Failure, Guidelines, Diagnosis, Treatment, Echocardiography, Anticoagulant Therapy, Atrial Fibrillation and Chamber Quantification.
- Renin-Angiotensin-Aldosterone System Inhibitors
- Myocardial Infarction
- Cardiac Risk
- Cardiac Resynchronization Therapy
- Extracorporeal Membrane Oxygenation
- Chamber Quantification
- Anticoagulant Therapy
- Treatment
- Guidelines
- Heart Failure
- Diagnosis
- Echocardiography
- Atrial Fibrillation
- Diastolic Function
- Left Ventricular Assist Device
- Implantable Cardioverter-Defibrillator
- Hyperkalemia
- Perioperative
- Ventricular Reconstruction
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Heart Failure1005 topics
- Guidelines783 topics
- Diagnosis551 topic
- Treatment551 topic
- Echocardiography262 topics
- Anticoagulant Therapy171 topic
- Atrial Fibrillation171 topic
- Chamber Quantification151 topic
- Diastolic Function151 topic
- Extracorporeal Membrane Oxygenation131 topic
- Left Ventricular Assist Device131 topic
- Cardiac Resynchronization Therapy111 topic
- Implantable Cardioverter-Defibrillator111 topic
- Cardiac Risk61 topic
- Hyperkalemia61 topic
- Myocardial Infarction61 topic
- Perioperative61 topic
- Renin-Angiotensin-Aldosterone System Inhibitors61 topic
- Ventricular Reconstruction61 topic
Where does Matti Kivikko work?
Matti Kivikko's main affiliation in the publication record is Orion Corporation (Finland), Finland.
How many publications and citations does Matti Kivikko have?
OpenAlex counts 62 works and 4,593 citations for Matti Kivikko, an h-index of 32, ranking #255,712 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Matti Kivikko. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.